Meeting NewsVideo

VIDEO: Genotyping may influence antiplatelet therapy prescriptions

In this Cardiology Today video exclusive, Sony Tuteja, PharmD, MS, research assistant professor of translational medicine and human genetics at Penn Medicine, and Jay S. Giri, MD, MPH, director of peripheral intervention and assistant professor of medicine at the Hospital of the University of Pennsylvania and a Cardiology Today Next Gen Innovator, discuss the results of the ADAPT trial.

The results of the study, presented at the American College of Cardiology Scientific Session, showed that performing a genetic test for nonresponse to clopidogrel frequently but not exclusively influences physician choice of antiplatelet prescription after PCI.

Watch the video for more.

 

 

In this Cardiology Today video exclusive, Sony Tuteja, PharmD, MS, research assistant professor of translational medicine and human genetics at Penn Medicine, and Jay S. Giri, MD, MPH, director of peripheral intervention and assistant professor of medicine at the Hospital of the University of Pennsylvania and a Cardiology Today Next Gen Innovator, discuss the results of the ADAPT trial.

The results of the study, presented at the American College of Cardiology Scientific Session, showed that performing a genetic test for nonresponse to clopidogrel frequently but not exclusively influences physician choice of antiplatelet prescription after PCI.

Watch the video for more.

 

 

    See more from American College of Cardiology Annual Scientific Session